Table 4.
Summary metrics for diabetes diagnosis, treatment, and control
| Key metrics | Total insured | Commercial | Medicare | Medicaid |
|---|---|---|---|---|
| Total with diabetes | 25,260,000 | 11,400,000 | 11,430,000 | 2,430,000 |
| Total undiagnosed | 6,920,000 | 3,110,000 | 3,150,000 | 660,000 |
| Percent of type 2 diabetes patients undiagnoseda | 27% | 27% | 28% | 27% |
| Diagnosed | 18,340,000 | 8,290,000 | 8,280,000 | 1,770,000 |
| Diagnosed type 1 | 1,450,000 | 1,070,000 | 200,000 | 180,000 |
| Diagnosed type 2 | 16,890,000 | 7,220,000 | 8,080,000 | 1,590,000 |
| % not receiving diabetes medication | 23% | 18% | 27% | 25% |
| Not receiving diabetes medication | 3,900,000 | 1,290,000 | 2,220,000 | 390,000 |
| Receiving diabetes medication | 12,990,000 | 5,930,000 | 5,860,000 | 1,200,000 |
| Poorly controlled diabetes | 5,550,000 | 2,450,000 | 2,590,000 | 510,000 |
| Controlled diabetes | 7,440,000 | 3,480,000 | 3,270,000 | 690,000 |
| % poorly controlled | 43% | 41% | 44% | 42% |
| Average increase in medical expenditures for uncontrolled diabetes | $4,860 | $6,680 | $3,430 | $4,260 |
aUndiagnosed cases in each age group are assumed to have the same proportion type 2 as diagnosed cases in each age group